Medicines With The Active Ingredient Octreotide (Atc: H01Cb02 - Retarded Dosage Forms)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 105350746

  Document Type - Tender Notices

Description - Description: Scope of procurementShort descriptionThe subject of this publication is the conclusion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for finished medicinal products with the active ingredient Octreotide (A TC: H01CB02-retarded dosage forms) as part of a so-called "open-house model". Under the specification of uniform contractual conditions and uniform access procedures, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies is offered to the conclusion or accession to a discount contract in accordance with Section 130a (8) SGB V for the aforementioned active ingredients or medicines. Interested pharmaceutica

Gt Ref Id - 105350746

Deadline - Feb 28, 2027